Earnings Feed
Start Free
Home/Filings/4/0000885590-10-000065
4//SEC Filing

Chouinard Michel 4

Accession 0000885590-10-000065

CIK 0000885590other
View on SEC.govCompany Profile

Filed

Dec 26, 7:00 PM ET

Accepted

Dec 27, 11:57 AM ET

Size

10.5 KB

Accession

0000885590-10-000065

Insider Transaction Report

Form 4
Period: 2010-12-22
Valeant Pharmaceuticals International, Inc.VRX
Chouinard Michel
COO, Biovail Labs.Int'l SRL
Transactions
  • Award

    Restricted Share Units

    2010-12-22+157→ 4,837 total
    From: 2012-02-25Exp: 2012-02-25→ Common Stock, no par value (157 underlying)
  • Award

    Restricted Share Units

    2010-12-22+148→ 4,584 total
    From: 2013-02-17Exp: 2013-02-17→ Common Stock, no par value (148 underlying)
  • Award

    Restricted Share Units

    2010-12-22+128→ 3,946 total
    From: 2011-03-12Exp: 2011-03-12→ Common Stock, no par value (128 underlying)
Footnotes (2)
  • [F1]Each Restricted Share Unit (RSU) represents a contingent right to receive one share of Common Stock, no par value, of Valeant Pharmaceuticals International, Inc. (the "Common Stock").
  • [F2]Represents dividend equivalents accrued on RSUs as a result of a dividend paid on the Common Stock on December 22, 2010.

Documents

1 file

Issuer

Valeant Pharmaceuticals International, Inc.

CIK 0000885590

→
Entity typeother

Related Parties

1
  • filerCIK 0001479927

Filing Metadata

Form type
4
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 11:57 AM ET
Size
10.5 KB
View on SEC.gov